Geron reported $-39948000 in Operating Profit for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Profit Change
Amgen AMGN:US USD 2.74B 562M
Cti Biopharma CTIC:US USD -12218000 6.66M
Cytokinetics CYTK:US USD -130687000 119.81M
Esperion Therapeutics ESPR:US USD -41623000 10.75M
Exelixis EXEL:US USD 82.61M 1.09M
Genmab GEN:DC DKK 1.93B 684M
Geron GERN:US USD -39948000 11.97M
Gilead Sciences GILD:US USD 2.84B 808M
Macrogenics MGNX:US USD -24955000 16.85M
Novartis NOVN:VX USD 2.17B 60M
Novavax NVAX:US USD -127189000 355.77M
Pain Therapeutics PTIE:US USD -21345000 1.43M
Seattle Genetics SGEN:US USD -192805000 59.69M
YTE INCY:US USD 138.38M 116.06M